Article
Loss-of-function variants in SRRM2 cause a neurodevelopmental disorder.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2022
Cuinat Silvestre, Nizon Mathilde, Isidor Bertrand, Stegmann Alexander, van Jaarsveld Richard H, van Gassen Koen L, van der Smagt Jasper J, Volker-Touw Catharina M L, Holwerda Sjoerd J B, Terhal Paulien A, Schuhmann Sarah, Vasileiou Georgia, Khalifa Mohamed, Nugud Alaa A, Yasaei Hemad, Ousager Lilian Bomme, Brasch-Andersen Charlotte, Deb Wallid, Besnard Thomas, Simon Marleen E H, Amsterdam Karin Huijsdens-van, Verbeek Nienke E, Matalon Dena, Dykzeul Natalie, White Shana, Spiteri Elizabeth, Devriendt Koen, Boogaerts Anneleen, Willemsen Marjolein, Brunner Han G, Sinnema Margje, De Vries Bert B A, Gerkes Erica H, Pfundt Rolph, Izumi Kosuke, Krantz Ian D, Xu Zhou L, Murrell Jill R, Valenzuela Irene, Cusco Ivon, Rovira-Moreno Eulàlia, Yang Yaping, Bizaoui Varoona, Patat Olivier, Faivre Laurence, Tran-Mau-Them Frederic, Vitobello Antonio, Denommé-Pichon Anne-Sophie, Philippe Christophe, Bezieau Stéphane, Cogné Benjamin
Abstract excerpt
PURPOSE: SRRM2 encodes the SRm300 protein, a splicing factor of the SR-related protein family characterized by its serine- and arginine-enriched domains. It promotes interactions between messenger RNA and the spliceosome catalytic machinery. This gene, predicted to be highly intolerant to loss of function (LoF) and very conserved through evolution, has not been previously reported in constitutive human disease....
Read the complete abstract on PubMed